Jaguar Health, Inc. (JAGX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.44
- As of
Kresmion compiles this page from JAGX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Jaguar Health, Inc. (JAGX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-06.
See the full JAGX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for JAGX on one page. Preview it with sample data, then open it live with a free account.
Preview the JAGX dossierActive events for JAGX
- mediumEarnings above estimates
Q1-2025: Beat consensus by 9.0% - EPS $-584.5 vs $-642.6 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 41.1% - EPS $-359.1 vs $-254.541 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 21.2% - EPS $-219.8 vs $-181.356 estimate
- mediumEarnings above estimates
Beat consensus by 9.0% - EPS $-584.5 vs $-642.6 estimate
- mediumEarnings below estimates
Missed consensus by 41.1% - EPS $-359.1 vs $-254.541 estimate
FREE, NO ACCOUNT
Every event on JAGX, as it fires
You are seeing 5 of 7 events recorded on JAGX since 2026-06-02.
The five above landed across 2 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, JAGX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
JAGX's 10-Q filed Aug 19, 2026 states:
These conditions raise substantial doubt about the Company's ability to continue as a going concern over the next 12 months after the date these financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on JAGX
JAGX against its peers
JAGX's operating margin of -398.8% ranks in the 61st percentile of 13 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-04-30.
| Metric | JAGX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 11.5M USD | 405000 USD | 97 | 17 |
| Gross margin | n/a | 20.4% | n/a | 7 |
| Operating margin | -398.8% | -1942.2% | 61 | 13 |
| Net margin | -465.4% | -1412.4% | 57 | 14 |
| Return on equity | n/a | -175.8% | n/a | 21 |
| 1 year | n/a | -73.8% | n/a | 16 |
Peers (22): PCSA, CDIO, PULM, BGMS, OSRH, SNGX, LGVN, ACXP, ALZN, NIKI, CANF, CNSY, TCRT, RVPH, EVGN, CELZ, CSCIF, CRIS, SNTI, IMNN, XCUR, KPRX. Left out: ADAPY (no annual filing), ADXN (period gap), ENVB (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (JAGX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in JAGX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on JAGX in the last 180 days.
Upstream: SEC EDGAR filings for JAGX
Kresmion, "Jaguar Health, Inc. (JAGX) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/JAGX. Upstream data: SEC EDGAR filings for JAGX.
Link to this data (HTML):
<a href="https://kresmion.com/research/JAGX">Jaguar Health, Inc. (JAGX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow JAGX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to JAGX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.